Annals of the ICRP
Volume 34, Issue 2 , Pages 29-52 , June 2004

Chapters 7–10

  • J. Valentine

      Affiliations

    • Corresponding Author InformationTel.: +46 8 729 7275; fax: +46 8 729 7298.

References 

  1. Barrington SF, Kettle AG, O’Doherty MJ, et al. Radiation dose rates from patients receiving iodine-131 therapy for carcinoma of the thyroid. Eur. J. Nucl. Med. 1996;23:123–130
  2. Barrington SF, Kettle AG, Thompson WH, Burrell DN, et al. RCP guidelines on radiation protection following radioiodine therapy for hyperthyroidism: are they appropriate?. Nucl. Med. Communic. 1996;17:275
  3. Barrington SF, O’Doherty MJ, Kettle AG, et al. Radiation exposure of families of outpatients treated with radioactive iodine (iodine-131) for hyperthyroidism. Eur. J. Nucl. Med. 1999;26:686–692
  4. Barrington SF, Anderson P, Kettle AG, et al. Does significant contamination occur in families of patients treated with 131-I for hyperthyroidism?. Eur. J. Nucl. Med. 2003;30(Suppl. 2):S164;(Abstract 69)
  5. British Institute of Radiology, 1999. Patients leaving hospital after administration of radioactive substances. Br. J. Radiol. 72, 121–125.
  6. Buchan RCT, Brindle MA. Radioiodine therapy to out-patients – the radiation hazard. Br. J. Radiol. 1971;44:973–975
  7. Buchan RCT, Brindle MA. Radioiodine therapy to out-patients – the contamination hazard. Br. J. Radiol. 1970;43:479–483
  8. Buettner C, Surks M. Police detainment of a patient following treatment with radioactive iodine. JAMA. 2003;288:2687–2688
  9. Castronovo FP, Beh RA, Veilleux NM. Iodine-131 therapy patients: radiation dose to staff. Radiat. Prot. Dosimetry. 1986;15:45–49
  10. Chavin W, Cukrowski CA. Effects of iodine-131 on the thyroid and pituitary of goldfish (carassius auratus). Radiat. Res. 1968;34:170–199
  11. Copplestone D, Toal MED, Johnson MS, et al. Environmental effects of radionuclides – observations on natural ecosystems. J. Radiat. Prot. 2000;20:29–40
  12. Crockett G. Sources and fate of discharges of liquid radioactive waste to public sewers. Radiol. Prot. Bull. 2000;226:19–24
  13. deKlerk JMH. Iodine-131 therapy: inpatient or outpatient?. J. Nucl. Med. 2000;41:1876–1878
  14. Denman AR, Martin S. Care of a terminally ill patient following a thyroid ablation dose of 131I sodium iodide. Br. J. Radiol. 2001;74:1077–1078
  15. Dickman P, Holm L, Lundell G, Boice J, Hall P. Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden. Int. J. Cancer. 2003;106:580–587
  16. Eisenbud M. Environmental Radioactivity. second ed.. New York: Academic Press; 1973;
  17. Erlandsson B, Mattsson S. Medically used radionuclides in sewage sludge. Water Air Soil Pollut. 1978;9:199–206
  18. Environment Agency, 2000. UK Investigation of the Sources and Fate of Radioactive Discharges into Public Sewers. R & D Technical Report P288. Environment Agency, London.
  19. European Commission, 1998. Radiation Protection 97, Radiation Protection Following Iodine-131 (Exposures due to Outpatients or Discharged Inpatients). European Commission, Luxembourg.
  20. Evdokimoff V, Cash C, Buckley K, Cardenas A. Potential for radioactive patient excreta in hospital trash and medical waste. Health Phys. 1994;66:209–211
  21. Fenner FD, Martin JE. Behavior of Na 131I and meta (131I) iodobenzylguanidine (MIBG) in municipal sewerage. Health Phys. 1997;73:333–339
  22. Griffiths PA, Jones GP, Marshall C, Powley SC. Radiation protection consequences of the care of a terminally ill patient having received a thyroid ablation dose of 131sodium iodide. Br. J. Radiol. 2000;73:1209–1212
  23. Gunesekera R, Thompson WH, Harding LK. Use of public transport by 131I therapy outpatients. Nucl. Med. Communic. 1996;17:275
  24. Harris PJ. A study of thyroid function in Fundulus heteroclitus (killifish). Biol. Bull. 1959;117:91–98
  25. Hilditch TE, Connell JMC, Davies DL, et al. Radiological protection guidance for radioactive patients – new data for therapeutic 131I. Nucl. Med. Communic. 1991;12:485–495
  26. Ho SY, Shearer DR. Radioactive contamination in hospitals from nuclear medicine patients. Health Phys. 1992;62:
  27. Homer L, Smith AH. Radiation protection issues of treating hyperthyroidism with 131I in patients on haemodialysis. Nucl. Med. Communic. 2002;23:261–264
  28. Ibis E, Wilson CR, Collier BD, et al. Iodine-131 contamination from thyroid cancer patients. J. Nucl. Med. 1992;33:2110–2115
  29. Ilyin L, Arkhangel’skaya GV, Konstantinov O, Likhtarev IA. Radioactive Iodine in the Problem of Radiation Safety. Moscow: Atomizdat; 1972;
  30. International Atomic Energy Agency, 2002b. Detection of Radioactive Materials at Borders, IAEA-TECDOC-1312. IAEA, Vienna.
  31. International Commission on Radiological Protection (1991) 1990 Recommendations of the International Commision of Radiological Protection. ICRP Publication 60, Ann. ICRP 21 (1–3).
  32. International Commission on Radiological Protection, 1997. Radiological protection policy for the disposal of radioactive waste. ICRP Publication 77, Ann. ICRP 27 (Suppl.).
  33. International Commission on Radiological Protection (2003) A framework for assessing the impact of ionising radiation on non-human species. ICRP Publication 91, Ann. ICRP 33(3).
  34. Jacobson AP, Plato PA, Toeroek D. Contamination of the home environment by patients treated with iodine-131: initial results. Am. J. Public Health. 1978;68:225–230
  35. Johnson TK, Lin E, Haugen B. Contamination as a route for 131I uptake in family members: implications for public health. J. Nucl. Med. 2002;43(Suppl.):abstract
  36. Kelly, J., Finch, H., 2002. Benchmarking Public Opinion on the Management of Radioactive Waste. A Report for the Radioactive Substances Division of the Department for the Environment, Food and Rural Affairs.
  37. Kerber R, Till J, Simon S, et al. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA. 1993;270:2076
  38. Larsen, P.R., Conard, R., 1978. Thyroid hypofunction appearing as a delayed manifestation of accidental exposure to radioactive fallout in a Marshallese population. Brookhaven National Laboratory Report BNL-24104.
  39. LaRoche G, LeBlond CP. Destruction of the thyroid gland of Atlantic salmon by means of radioiodine. Proc. Soc. Exp. Biol. Med. 1954;87:273–276
  40. LaRoche G, Johnson CL, Woodall AN. Thyroid function in the rainbow trout: biological and histological evidence of radiothyroidectomy. Gen. Comp. Endocrinol. 1965;5:145–159
  41. Leslie WD, Havelock J, Palser R, Abrams DN. Large-body radiation doses following radioiodine therapy. Nucl. Med. Communic. 2002;23:1091–1097
  42. Leung PM, Nikolic M. Disposal of therapeutic iodine-131 waste using a multiple holding tank system. Health Phys. 1998;75:315–321
  43. Martin JE, Fenner FD. Radioactivity in municipal sewerage and sludge. Public Health Rep. 1997;308–316
  44. Marcus CS, Aldrich R. Avoiding solid waste contamination problems from iodine-131 patients. J. Nucl. Med. 1997;38:26N
  45. Mathieu I, Caussin J, Smeesters P, Wamberseie A, Beckers C. Doses in family members after 131I treatment. Lancet. 1997;350:1074–1075
  46. Mathieu I, Caussin J, Smeesters P, et al. Recommended restrictions after iodine-131 therapy: measured doses in family members. Health Phys. 1999;76:129–136
  47. Meck RA. Complete decay of radionuclides: implications for low-level waste disposal in municipal landfills. Health Phys. 1996;70:706–7111
  48. Monsieurs M, Thierens H, Dierckx RA, et al. Real-life radiation burden to relatives of patients treated with iodine-131: a study in 8 centers in Flanders (Belgium). Eur. J. Nucl. Med. 1998;25:1368–1376
  49. Moreno Garcia, L., 2001. Expectations of Patients’ Advocates, Radiological Protection of Patients in Diagnostic and Interventional Radiology, Nuclear Medicine and Radiotherapy. Proceedings of an International Conference, Malaga, 26–30 March 2001. International Atomic Energy Agency, Vienna.
  50. Norris DO, Gorbman A. Radiothyroidectomy of larval steelhead trout. Proc. Soc. Exp. Biol. Med. 1965;119:1205–1207
  51. Nuclear Energy Agency, 1995. The Environmental and Ethical Basis of Geological Disposal of Long-lived Radioactive Wastes. A Collective Opinion of the Radioactive Waste Management Committee of the OECD Nuclear Energy Agency. NEA, Paris.
  52. O’Doherty MJ, Kettle AG, Eustance CNP, et al. Radiation dose rates from adult patients receiving 131I therapy for hyperthyroidism. Nucl. Med. Communic. 1993;14:160–168
  53. Olivereau M, LaRoche G. Effects of low iodine intake or destructive doses of iodine-131 on pituitary histochemistry of young Chinook salmon. Am. Zoologist. 1965;5:234
  54. Olivereau M. Radiothyroidectomie chez l’Anguille. Arch. Anat. Microscop. Morphol. Exptl. 1957;46:39–59
  55. Pentreath RJ. Radiation protection of people and the environment: developing a common approach. J. Radiolog. Protect. 2002;22:45–46
  56. Prichard HM, Gesell TF, Davis E. Iodine-131 levels in sludge and treated municipal wastewaters near a large medical complex. Am. J. Public Health. 1981;71:47–52
  57. Rallison ML, Dobyns BM, Keating FR, et al. Thyroid disease in children: a survey of subjects potentially exposed to fallout radiation. Am. J. Med. 1974;56:457–463
  58. Reiners C, Lassmann M. Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance. Eur. J. Nucl. Med. 1999;26:683–685
  59. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 1995;141:259–277
  60. Saenger EL, Kereiakes JG. Reflections on cancer treatment and the federal agency regulations. Radiology. 1980;137:865–866
  61. Shishkanov NG, Bakun YM, Roziev RA, et al. Radiation protection of members of the public contacting patients after therapeutic treatment with radioiodine. Med. Radiol. Radiat. Protect. 2001;5:34–46(in Russian)
  62. Siegel, J.A., 1999. Outpatient Radionuclide Therapy. Proceedings of the Thirty-Fifth Annual Meeting of the National Council on Radiation Protection and Measurements, Proceedings No. 21, 7–8 April 1999, Arlington VA. NCRP, Bethesda.
  63. Siegel JA, Sparks RB. Radioactivity appearing at landfills in household trash of nuclear medicine patients: much ado about nothing?. Health Phys. 2002;82:367–372
  64. Sodd VJ, Velten RJ, Saenger EL. Concentrations of the medically useful radionuclides, technetium-99m and iodine-131 at a large metropolitan waste water treatment plant. Health Phys. 1975;28:355–359
  65. UK Department of the Environment, 2002. UK Strategy for Radioactive Discharges 2001–2020. Department for Environment, Food and Rural Affairs, London.
  66. United Nations Scientific Committee on the Effects of Atomic Radiation, 2000. Sources and Effects of Ionizing Radiation. 2000 Report to the General Assembly with Annexes, United Nations, Vienna.
  67. US Nuclear Regulatory Commission, 1997b. Release of Patients Administered Radioactive Materials. Regulatory Guide 8.39. USNRC, Washington.

PII: S0146-6453(04)00020-X

doi: 10.1016/j.icrp.2004.08.005

Annals of the ICRP
Volume 34, Issue 2 , Pages 29-52 , June 2004

Article Tools